首页> 外国专利> (Vita) chemotherapy for a variety of cancers without major or moderate adverse effects.

(Vita) chemotherapy for a variety of cancers without major or moderate adverse effects.

机译:(Vita)化疗可治疗多种癌症,而没有严重或中度的不良反应。

摘要

Novel combinations of different biological agents have led to the formation of intravenous therapeutic formulations. Treatment of six types of cancer, namely: breast cancer, ovarian cancer, prostate cancer, gastric cancer, bladder cancer, the trial program was prepared for 40 months. The formula was tested in comparison with cispl treatment.Atine de Mylan et traite“` 5-fluuracile'”de Teva. Compared with other treatments on the market, this treatment is more advantageous because it provides induction of the cell death process of cancer cells in a time shorter than cell death time by using other agents. alsoVitamin preparations induce "... Selective" apoptosis without significant or moderate negative effects. This formula is strictly applied to the pharmaceutical industry.
机译:不同生物制剂的新颖组合已导致形成静脉内治疗制剂。治疗六种类型的癌症,即:乳腺癌,卵巢癌,前列腺癌,胃癌,膀胱癌,该试验程序准备了40个月。将该配方与cispl处理进行了比较。Atinede Mylan et traite“ 5-fluuracile” de Teva。与市场上的其他治疗方法相比,该治疗方法更具优势,因为通过使用其他试剂,该方法可在比细胞死亡时间短的时间内诱导癌细胞的细胞死亡过程。维生素制剂还可以诱导“ ...选择性”凋亡,而没有明显或中等程度的负面影响。此公式严格适用于制药行业。

著录项

  • 公开/公告号TN2019000004A1

    专利类型

  • 公开/公告日2020-07-15

    原文格式PDF

  • 申请/专利权人 ABIR GHIDHAOUI;

    申请/专利号TN20190000004

  • 发明设计人 ABIR GHIDHAOUI;

    申请日2019-01-08

  • 分类号A61P35;

  • 国家 TN

  • 入库时间 2022-08-21 11:16:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号